Arrowhead Pharmaceuticals
The Associate Director of Medical Value, Evidence, and Outcomes supports the development and execution of medical value evidence strategies for Arrowhead's cardiometabolic portfolio, including the investigational siRNA therapeutic plozasiran. This role involves contributing to evidence generation, real-world evidence initiatives, and payer-focused scientific communication to support development and commercialization objectives. The position requires translating clinical, epidemiologic, economic, and real-world data into medically rigorous materials to facilitate evidence-based decision-making and stakeholder engagement.
Headquarters
Pasadena, California, United States
Company Size
501-1000 employees
Founded
2004
Arrowhead Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and delivers RNA interference (RNAi)-based therapeutics to silence disease-causing genes. Using proprietary targeted delivery platforms that enable focused, durable gene knockdown, Arrowhead advances programs across liver and extra‑hepatic indications including cardiometabolic, pulmonary, viral, and rare diseases. The company progresses multiple clinical and preclinical candidates and collaborates with partners to translate RNAi science into new therapies that aim to change how diseases are treated.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arrowhead Pharmaceuticals.
13% below the average for this role
Associate Director, Outcomes Research
MSD
Medical Evidence Strategy Director
AstraZeneca
HTA, Value & Evidence Senior Manager
Pfizer
Senior Director, Real World Evidence (Center of Excellence Lead)
Crinetics Pharmaceuticals
Director, HTA, Value & Evidence (HV&E) – Internal Medicine Early Pipeline
Pfizer
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc